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This randomized clinical trial investigated the effectiveness of exercise vs. exercise 37 
plus trigger point dry needling (TrP-DN) in subacromial pain syndrome. A randomized 38 
parallel-group trial, with 1-year follow-up was conducted. Fifty subjects with subacromial 39 
pain syndrome were randomly allocated to receive exrcise alone or exercise +TrP-DN. 40 
Participants in both groups were asked to perform an exercise program of the rotator cuff 41 
muscles twice daily for 5 weeks. Further, patients allocated to the exercise +TrP-DN group 42 
also received dry needling to active TrPs in the muscles reproducing shoulder symptoms 43 
during the 2nd and 4th sessions. The primary outcome was pain-related disability assessed 44 
with the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. Secondary 45 
outcomes included mean current pain and the worst pain experienced in the shoulder during 46 
the previous week. They were assessed at baseline, one week, and 3, 6, and 12 months after 47 
the end of treatment. Analysis was by intention to treat with mixed ANCOVA adjusted for 48 
baseline outcomes. At 12 months, 47 (94%) patients completed follow-up. Statistically 49 
larger improvements (all, P<0.01) in shoulder disability was found for the exercise +TrP-50 
DN group at all follow up periods [post: ∆ -20.6 (-23.8 to -17.4); 3 months: ∆ -23.2 (-28.3 51 
to -18.1); 6 months: ∆ -23.6 (-28.9 to -18.3); 12 months: ∆ -13.9 (-17.5 to -10.3). Both 52 
groups exhibited similar improvements in shoulder pain outcomes at all follow-up periods. 53 
The inclusion of TrP-DN to an exercise program was effective for improving disability in 54 
subacromial pain syndrome. No greater improvements in shoulder pain were observed. 55 
Trial registration: http://www.clinicaltrials.gov, ClinicalTrials.gov, NCT02338908. 56 



















        This study found that the inclusion of two sessions f trigger point dry needling into 62 
an exercise program was effective for improving shoulder pain-related disability at short-, 63 































Exercises and Dry Needling for Subacromial Pain Syndrome: a 81 
Randomized Parallel-Group Trial 82 
 83 
Introduction  84 
Shoulder pain is a significant health problem presenting a prevalence of 25% in the 85 
general population.25 Tekavec et al found that the most prevalent diagnosis is subacromial 86 
pain syndrome.32 The societal burden of shoulder pain is substantial with annual costs per 87 
patient estimated at €4139 in primary health care33 and direct costs for the treatment of 88 
shoulder disorders in the United States over $7 billion.28 89 
Conservative treatment is the first therapeutic option for individuals with shoulder 90 
pain;13 however the most appropriate treatment strategy is unclear. Therapeutic exercise 91 
probably exhibits the highest level of evidence for the treatment of shoulder pain conditions 92 
including subacromial pain syndrome,27,30 although further trials are required.12 In fact, the 93 
Dutch Orthopedic Association Clinical Practice Guideline for subacromial pain syndrome 94 
recommends exercise as the first therapeutic option, but also that inactivation of trigger 95 
points (TrPs) shoulder be considered.8 TrPs are defined as hypersensitive tender spots 96 
within taut bands of skeletal muscles that are painful, elicit a referred pain, and generate 97 
motor dysfunctions.31 Previous studies have demonstrated that active TrPs in the shoulder 98 
muscles reproduce symptoms suffered by subjects with subacromial pain syndrome.4,16 99 
   Several therapeutic approaches, pharmacological and non-pharmacological, are proposed 100 
for the management of active TrPs, with manual therapi s, trigger point injections,  and dry 101 















manual therapy targeting active TrPs in the shoulder musculature is effective for reducing 103 
pain and improving function in individuals with shoulder pain in the short-term,3 but there 104 
is no evidence on mid- and long-term effects. Dry needling (TrP-DN) is defined as a 105 
“skilled intervention using a thin filiform needle to penetrate the skin that stimulates TrPs, 106 
muscles, and connective tissue for the management of musculoskeletal disorders”.2 Recent 107 
meta-analyses suggest that TrP-DN may be effective for neck and shoulder pain 108 
immediately after and at medium terms.21,23 However, no study has investigated long-term 109 
effects of TrP-DN in patients with shoulder pain. Our objective was to conduct a 110 
randomized clinical trial to compare the 1-year effectiveness on pain and disability of the 111 
inclusion of TrP-DN into an exercise program for peo l  with subacromial pain syndrome.  112 
 113 
Methods 114 
Study Design  115 
           This randomized, parallel-group clinical trial compared 2 treatments for subacromial 116 
pain syndrome: exercise only and TrP-DN plus exercis . The primary end point was 1-year 117 
improvement shoulder pain-related disability. Secondary outcomes included the current 118 
mean of shoulder pain and the worst level of pain experienced in the preceding week in the 119 
shoulder. The current report follows the CONSORT (Consolidated Standards of Reporting 120 
Trials) extension for clinical trials.35 The study was approved by the Institutional Review 121 
Board of Universidad Rey Juan Carlos (URJC 31/2014) and the clinical trial was registered 122 

















Consecutive subjects with a diagnosis of subacromial pain syndrome from a local 126 
regional Hospital (Madrid, Spain) were screened for eligibility criteria. Participants were 127 
invited to participate into the study during routine medical visit. To be eligible, they had to 128 
fulfill the following criteria: 1, unilateral non-traumatic shoulder pain; 2, shoulder pain 129 
from at least 3 months; and, 3, pain intensity of at le st 4 points on an 11-point numerical 130 
pain rate scale (NPRS). In our study, subacromial pain syndrome was diagnosed following 131 
the Dutch Orthopedic Association Clinical Practice Guideline where a cluster of tests has 132 
been proposed. Therefore, patients were diagnosed wh n they exhibited a positive painful 133 
arc test during shoulder abduction (+LR 3.7, 95%CI 1.9-7.0),14 and at least 2 positive of the 134 
following clinical tests: Hawkins-Kennedy test (+LR 1.70, 95%CI 1.29-2.26), Neer’s sign 135 
(+LR 1.86, 1.49-2.31), empty can test (specificity 0.62), drop arm test (specificity 0.92), or 136 
lift-off test (specificity 0.97).1 Patients were excluded if they exhibited: 1, bilater l shoulder 137 
symptoms; 2, younger than 18 or older than 65 years; 3, history of shoulder fractures or 138 
dislocation; 4, diagnosis of cervical radiculopathy; 5, previous interventions with steroid 139 
injections in the shoulder area; 6, fibromyalgia syndrome; 7, previous history of shoulder or 140 
neck surgery; or, 8, any type of intervention for the neck-shoulder area during the previous 141 
year. Additionally, since fear of needles is present in around 20-25% of subjects attending 142 
general medical practice34, we also excluded patients with fear of needles and coagulation 143 
disorders for avoiding any potential risk on the exp rimental group. All participants signed 144 

















Randomization and masking 148 
Patients were randomly assigned to receive TrP-DN plus exercise or exercise alone. 149 
Concealed allocation was done using a computer-generated randomized table of numbers 150 
created by a statistician who do not participate in the main trial. Individual and sequentially 151 
numbered index cards with the random assignment were prepared, folded, and placed in 152 
sealed opaque envelopes. A second external researcher opened the envelope and proceeded 153 
with allocation. Examiners blinded to group allocation obtained all outcome measures.  154 
Interventions 155 
          Both groups received the same exercise program. No consensus exists on what 156 
exercises should be applied on individuals experiencing subacromial pain syndrome; 157 
however, it is recommended that they should be specific and of low intensity and high 158 
frequency.5,8 Therefore, each exercise was performed in 3 sets of 12 repetitions. Each 159 
repetition included the concentric phase and after th  eccentric phase of the exercise, which 160 
was slowly conducted. The program consisted of 3 exercises focusing on supraspinatus, 161 
infraspinatus, and scapular stabilizer musculature. Th  exercise program was taught by an 162 
experienced physical therapist in the 1st session and monitored in subsequent 4 sessions, 163 
once per week during the treatment period. Each session lasted approximately 20-25min. 164 
Participants were asked to perform the exercise program on an individual basis twice every 165 
day for 5 weeks. They were monitored during all the treatment period for proper adherence 166 
to the exercise protocol for obtaining a 90%-95% rate of daily practice. During the follow-167 
up period, participants were asked for doing exercis  at demand, which was monitored on 168 















Patients allocated to the TrP-DN group also received TrP-DN to active TrPs in those 170 
shoulder muscles which referred pain or reproduced shoulder symptoms during the second 171 
and fourth treatment sessions. Therefore, patients allocated to this group received the same 172 
instructions for the exercise program in the first session, and TrP-DN during the 2nd and 4th 173 
sessions where participants also performed the exercise program monitored by the clinician. 174 
The muscles included in physical examination included the anterior and middle deltoid, 175 
supraspinatus, infraspinatus, teres minor and major, nd subscapularis.4,16 Since some 176 
muscles can exhibit multiple TrPs10 a clinically pragmatic approach was applied. Therefore, 177 
if multiple active TrPs were found, the clinician selected the most painful for receiving 178 
TrP-DN. Participants received TrP-DN with disposable stainless steel needles of 179 
0.32mm*40mm (Novasan©, Madrid, Spain) that were inserted into the skin over the TrP. 180 
In this study, the fast-in and fast-out technique described by Hong17 was applied. Once the 181 
active TrP was located, the overlying skin was cleaned with alcohol. The needle was 182 
inserted penetrating the skin into the TrP area until the first local twitch response was 183 
obtained. The depth of the needle depended on the muscle and ranged from 10-15 mm for 184 
the infraspinatus (Fig. 1) or deltoid (Fig. 2) muscles to 30-35 mm for the supraspinatus and 185 
teres major and minor muscles. Hong17 suggested that local twitch responses should be 186 
elicited during TrP-DN for a proper and successful technique. Once the first local twitch 187 
response was obtained, the needling was hence moved up and down (3 to 5 mm. vertical 188 
motions with no rotations) at approximately 1Hz until o more local twitch responses were 189 
elicited. TrP-DN intervention had a mean duration of 5-10 min in all participants. TrP-DN 190 
was applied by a physical therapist with 10 years of clinical experience in this therapeutic 191 















Outcome Measures 193 
Clinical records of all subjects included questions regarding the location, intensity, 194 
and duration of the symptoms, aggravating and relieving factors, and previous treatments. 195 
Pain and related-disability outcomes were assessed at baseline (pre), one week after the last 196 
treatment (post), and 3, 6, and 12 months after the end of therapy. It has been found that the 197 
intensity of shoulder pain and related-disability are highly associated in patients with 198 
subacromial shoulder pain;22 however, shoulder related-disability is the strongest predictor 199 
for physical therapy interventions.6 Therefore, we decided shoulder related-disability as the 200 
primary outcome. Related-disability was assessed with the Disabilities of the Arm, 201 
Shoulder and Hand (DASH) questionnaire.18 It consists of 30-items assessing: 1, degree of 202 
difficulty during the preceding week in performing physical activities because of problems 203 
in the upper extremity (21 items); 2, severity of each pain symptom, activity-related pain, 204 
tingling, weakness, and stiffness (5 items); and, 3, the problem’s effect on social activities, 205 
work, and sleep, and its psychological impact (4 items). Each item is answered on a 5points 206 
scale ranging from 1 (no difficulty to perform, no symptom, or no impact) to 5 (unable to 207 
do, very severe symptom, or high impact). Responses are ummed to form a raw score that 208 
is converted to a 0 to 100 scale where higher score reflect greater related-disability.18 The 209 
Spanish version of the DASH has shown high internal consistency (Cronbach α: 0.96) and 210 
excellent test-retest reliability (r: 0.96).15 It has been recently reported that the MCID for 211 

















The secondary outcome was the intensity of shoulder pain. An 11-points NPRS (0: 215 
no pain; 10: maximum pain) was used to assess the pati nts’ current level of shoulder pain 216 
and the worst level of pain experienced in the preceding week.20 Mintken et al29 found that 217 
the MCID for the NPRS in individuals with shoulder pain was 1.1 points. 218 
We also defined a successful outcome when patients observed a 50% improvement 219 
from baseline in DASH at 6 and 12 months follow-up periods. 220 
Treatment Side Effects  221 
Patients were asked to report any adverse event that they experienced either after the 222 
intervention or during any other part of the study. In the current study, an adverse event was 223 
defined as sequelae with any symptom perceived as distressing and unacceptable to the 224 
patient and required further treatment.  225 
Sample size determination 226 
     The sample size calculations were based on detecting between-groups differences of 227 
10.8 points (MCID) on the main outcome measure,9 assuming a standard deviation of 10.5, 228 
a 2-tailed test, an alpha level (α) of 0.05 and a desired power (β) of 90%. The estimated 229 
desired sample size was calculated to be at least 21 ubjects per group. A dropout rate of 230 
15% was expected, so 25 patients were included in each group. 231 
Statistical Analysis  232 
Statistical analysis was performed using SPSS software, version 21.0 (Chicago, IL, 233 
USA) and it was conducted according to intention-to-treat analysis for patients in the group 234 
to which they were allocated. Baseline demographic and clinical variables were compared 235 
between both groups using independent Student t-tess for continuous data and χ2 tests of 236 















measured analyses of covariance (ANCOVA) with time as the within-subjects factor, group 238 
as the between-subjects factor, and adjusted for baseline outcomes for evaluating between-239 
group differences in all the outcomes. Gender was also included in the main analysis as 240 
covariate. We used χ2 tests to compare success rate at 6 and 12 months between groups. To 241 
enable comparison of effect sizes, standardized mean score differences (SMDs) were 242 




 Between January and March 2015, 60 consecutive individuals with shoulder pain 247 
were screened for eligibility criteria. Fifty (83%) satisfied all criteria, agreed to participate, 248 
and were randomly allocated into exercise (n=25) or TrP-DN plus exercise (n=25) group. 249 
Randomization resulted in similar baseline features for all variables (TABLE 1).  250 
 Within patients allocated to the exercise group, 2 were lost at 12 months of follow-251 
up because they received corticosteroid injection in the shoulder, whereas 1 patient 252 
allocated to the exercise + TrP-DN group was lost at 6-months follow-up due to a whiplash 253 
injury. The reasons for ineligibility can be found in Fig. 3, which provides a flow diagram 254 
of patient recruitment and retention. None of the participants in either group reported any 255 
other therapeutic intervention during the study, excluding the use of NSAID at demand but 256 
sporadically. In fact, most participants reported that they did not continue with the exercise 257 
program during the follow-up period, only sporadically when they have an exacerbation of 258 















soreness after the first DN session which resolved spontaneously within 24-36 hours. No 260 
clinical adverse events were reported by the participants.  261 
Adjusting for baseline outcomes, the mixed-model ANCOVA observed significant 262 
Group*Time interaction for DASH (F=13.449; P<0.001). Patients receiving exercise plus 263 
TrP-DN exhibited higher improvements in function at all follow-up periods [immediately 264 
after: ∆ -20.6 (-23.8 to -17.4); 3 months: ∆ -23.2 (-28.3 to -18.1); 6 months: ∆ -23.6 (-28.9 265 
to -18.3); and 12 months: ∆ -13.9 (-17.5 to -10.3), all P<0.001] than those receiving the 266 
exercise protocol alone (Fig. 4). Between-group effect sizes were large at all folow-up 267 
periods (1.1>SMD>1.6) in favor of the exercise plus TrP-DN group. The inclusion of 268 
gender as covariate did not influence the results on houlder disability (F=0.861; P=0.358). 269 
The ANCOVA did not reveal significant Group*Time interactions for mean current 270 
(F=0.307; P=0.582) and the worst intensity (F=0.187; P=0.668) of shoulder pain: both 271 
groups get similar changes in shoulder pain at all follow-up periods (TABLE 2). No 272 
significant between-groups differences were observed at any follow-up period (P>0.43). 273 
Both groups exhibited moderate to large within-group effect sizes (0.7> SMD>1.4) at 3, 6 274 
and 12 months follow-ups (Fig. 4). Again, these results were not significantly different by 275 
gender (mean pain: F=0.409, P=0.536; the worst experienced pain: F=0.020, P=0.888) 276 
 A greater number of patients allocated to the exercis  + TrP-DN group experienced 277 
a successful outcome in the intention-to-treat analyses at 6 (P<0.001) and 12 (P=0.0.47) 278 




















          This is the first study investigating the effect of adding TrP-DN to a standard exercise 285 
intervention for the treatment of subacromial pain sy drome. This randomized clinical trial 286 
found that inclusion of TrP-DN into an exercise program resulted in higher improvements 287 
on shoulder related-disability in subjects with subacromial pain syndrome at 3, 6 and 12 288 
month follow-ups. No significant differences in shoulder pain were observed, rather, both 289 
groups experienced similar improvements from baseline to all follow-up periods. 290 
The Dutch Orthopedic Association Clinical Practice Guideline proposes the use of 291 
exercises for the management of individuals with subacromial pain syndrome.8 Further, 292 
recent systematic reviews also support the effectivness of exercise in subacromial shoulder 293 
pain.27,30 Our study found that both groups experienced similar decrease in mean current 294 
and the worst shoulder pain supporting the effectivness of exercises for the management 295 
of subacromial pain syndrome. Within-group change scores and their 95% confidence 296 
intervals surpassed the MCID of 1.1 points for shoulder pain29 at 3, 6 and 12 months in 297 
both groups, supporting a clinical effect of the exrcise program at a medium and long-term 298 
follow-up. It is interesting to note that no changes in shoulder pain outcomes were observed 299 
in either group at 1 week post-intervention. It is possible that that dosage of exercise, the 300 
exercise loading strategy, or the exercises included in our program can explain this finding. 301 
In fact, no consensus exists on which exercise program is the best for the treatment of 302 
subacromial pain disorders.5,8 303 
The novelty of this clinical trial was the application of TrP-DN for the management 304 
of subacromial pain syndrome. We observed that subjects receiving TrP-DN in addition to 305 















periods than those individuals who received exercis program alone. In this case, between-307 
group change scores and their 95% confidence intervals surpassed the MCID of 10.8 points 308 
for shoulder pain related-disability9 in favor of the TrP-DN group at all follow-up periods, 309 
supporting a clinical effect of this intervention. This was supported by the fact that all 310 
patients allocated to the TrP-DN group attained a successful treatment outcome for pain-311 
related disability (reduction of at least 50%) at 6 and 12 months.  312 
There is evidence suggesting that TrPs are related to the presence of altered motor 313 
control patterns,24 accelerated muscle fatigability,11 and increased motor activation19 in the 314 
affected and related musculature. Therefore, treatmnt of TrPs may effectively reduce these 315 
motor disturbances, improve motor function, and hence decrease pain-related disability. In 316 
fact, Bron et al4 found that the number of active TrPs was moderately correlated with the 317 
DASH score in patients with shoulder pain, which could explain the current results. It is 318 
plausible that TrP-DN applied on the shoulder musculature at the beginning of an exercise 319 
program can improve the motor output of the shoulder stabilizers and facilitate proper 320 
shoulder function.  321 
The results of this study should be considered according to potential strengths and 322 
limitations. Major strengths included that the study was prospectively registered, adhered to 323 
strict CONSORT guidelines, used blinded outcome assssment, concealed allocation, and 324 
intention-to-treat analysis. Further, the trial had high retention rates at 12 months follow-up. 325 
Among the limitations, first was that we recruited from a single clinic which may decrease 326 
the generalization of our results. Multi-centre studies controlling for site and clinician 327 
effects (cluster effects) in future trials might enha ce the generalizability. Second, because 328 















improvements are due to natural history of the condition, although this in unlikely due to 330 
chronicity of the symptoms. Third, we did not include a sham needling technique, so we 331 
cannot be sure that the benefit of TrP-DN was not simply due to placebo. Nevertheless, a 332 
recent meta-analysis concluded that real needling therapy is significantly superior to sham 333 
needling irrespective of the subtype of control or sham procedure.26 This can be also related 334 
to the fact that we did not assess potential expectations of the participants to receive any 335 
therapeutic intervention which could potentially affect the results. Fourth, subjects allocated 336 
to the TrP-DN group received 2 sessions based on the author clinical experience since no 337 
current scientific data exists on the adequate frequency and dose of therapy. We do not 338 
know if a greater number of sessions would result in larger differences between 339 
interventions. Finally, since dry needling is applied to active TrPs, it is possible subgroups 340 
of individuals with subacromial pain syndrome without active TrPs would not benefit from 341 
this intervention. However, we contend that these factors would be unlikely to change the 342 
overall conclusion of the study.  343 
 344 
Conclusions 345 
         In conclusion, our data indicate that the inclusion of TrP-DN into an exercise program 346 
resulted in larger clinical improvement in shoulder pain-related disability in individuals 347 
with subacromial pain syndrome. The inclusion of TrP-DN did not influence change in 348 
shoulder pain since both groups exhibited similar improvements at all follow-up periods. 349 
The current trial suggests that TrP-DN can be clinically used for improving effects of 350 
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Legend of Tables 496 
Table 1: Baseline characteristics by treatment assignment 497 
Table 2: Primary and secondary outcomes before and after intrvention, 3, 6 498 
and 12 months by randomized treatment assignment  499 
Table 3: Follow-up successful outcomes (50% improvement in DASH) by 500 
randomized treatment assignment [n (%)] 501 
 502 
Legend of Figures 503 
Figure 1: Dry needling on active trigger points (TrPs) in the infraspinatus muscle. 504 
Copyright, David G Simons Academy™, Switzerland©, with permission 505 
Figure 2: Dry needling on active trigger points (TrPs) in the deltoid muscle. 506 
Copyright, David G Simons Academy™, Switzerland©, with permission 507 
Figure 3: Flow diagram of patients throughout the course of the study. 508 
Figure 4: Evolution of all the outcomes (pain on top and DASH on bottom) 509 
throughout the course of the study stratified by randomised treatment assignment. 510 

































 Exercise Group (n=25) TrP-DN + exercise Group (n=25) 
Gender (male/female) 19 (76%) / 6 (24%) 18 (72%) / 7 (28%) 
Age (years) 48 ± 6 49 ± 5 
Years with pain  6.2 ± 1.9 5.8 ± 1.7 
Side of the symptoms n (%) 
Right side  







Mean intensity of shoulder pain (NPRS, 0-10) 6.6 ± 1.5 7.2 ± 1.6 
Worst pain experienced last week ( NPRS, 0-10) 7.8 ± 0.7 8.1 ± 0.9 



























Outcome Group Pre-intervention Post-intervention  3 months 6 months 12 months 
Mean intensity of shoulder pain (NPRS, 0-10) 
Exercise 6.6 ± 1.5 (6.0, 7.2) 6.0 ± 2.4 (5.0, 7.0) 3.4 ± 1.6(2.4, 4.5) 2.1 ± 1.9 (1.3, 2.9) 1.6 ± 1.5 (0.8, 2.3) 
TrP-DN + exercise 7.2 ± 1.6 (6.6, 7.9) 5.9 ± 2.5 (4.9, 6.9) 3.8 ± 1.5(2.7, 4.8) 1.9 ± 2.0 (1.2, 2.8) 1.5 ± 1.4 (0.9, 2.2) 
Worst level of shoulder pain experiencing preceding week (NPRS, 0-10) 
Exercise 7.8 ± 0.7 (7.4, 8.2) 5.2 ± 2.7 (4.7, 5.8) 3.3 ± 2.6(2.6, 4.0) 2.4 ± 2.5 (1.9, 3.0) 2.0 ± 1.6 (1.5, 2.5) 
TrP-DN + exercise 8.1 ± 0.9 (7.7, 8.4) 5.5 ± 2.7 (5.1, 6.1) 2.9 ± 3.0(2.2, 3.6) 1.9 ± 3.3 (1.4, 2.5) 1.6 ± 1.9 (1.1, 2.1) 
DASH (0-100) 
Exercise 62.0 ± 8.1(59.0, 65.0) 43.8 ± 6.4 (41.5, 46.1) 33.8 ± 12.0 (30.2, 37.4) 26.9 ± 12.8 (23.2, 30.7) 15.5 ± 11.1 (12.2, 18.8) 














Table 3: Follow-up successful outcomes (50% improvement in DASH) by randomized treatment assignment [n (%)] 
 
 
 6 months follow-up 12 months follow-up 
 Exercise alone (n=25) Exercise + TrP-DN (n=24) Exercise alone (n=23) Exercise + TrP-DN (n=24) 
Successful outcome 15 (60%) 24 (100%) 19 (82%) 24 (100%) 
Non-successful outcome 10 (40%) 0 (0%) 4 (18%) 0 (0%) 
 

























































Patients with shoulder pain screened for 
eligibility criteria (n=60) 
Excluded (n=10): 
Fear of needles (n=4) 
Previous steroid injections (n=3) 
No active TrPs (n=3) 
Baseline Measurements (n=50) 
Pain and DASH 
Randomized (n=50) 
Allocated to exercise alone (n=25) 
Immediate follow-up (n=25) 
Allocated to exercise + TrP-DN (n=25)  
Immediate follow-up (n=25) 
Three-months follow-up (n=25) Three-months follow-up (n=25) 
 
Six-months follow-up (n=24) 
1 lost to follow-up: whiplash injury 
Six-months follow-up (n=25) 
 
Twelve-months follow-up (n=23) 
2 lost to follow-up: received 




























• We examine effectiveness the inclusion of trigger point dry needling into an 
exercise program for the management of subacromial pain syndrome 
• The inclusion of trigger point dry needling was effective for decreasing shoulder 
pain-related disability at short, medium- and long-term follow-ups 
• The inclusion of trigger point dry needling was not related to greater decreases 
in shoulder pain outcomes at short, medium- and long-term follow-ups 
 
 
 
